Prazosin hydrochloride - Generic Drug Details

✉ Email this page to a colleague

What are the generic sources for prazosin hydrochloride and what is the scope of freedom to operate?

Prazosin hydrochloride is the generic ingredient in three branded drugs marketed by Pfizer, Alembic, Am Therap, Ani Pharms, Appco, Aurobindo Pharma Ltd, Dava Pharms Inc, Granules, Lannett Co Inc, Mankind Pharma, MSN, Mylan, Novitium Pharma, Purepac Pharm, Teva Pharms, and Watson Labs, and is included in twenty-five NDAs. Additional information is available in the individual branded drug profile pages.

There are fourteen drug master file entries for prazosin hydrochloride. Thirty suppliers are listed for this compound.

Summary for prazosin hydrochloride

US Patents:	0
Tradenames:	3
Applicants:	16
NDAs:	25
Drug Master File Entries:	14
Finished Product Suppliers / Packagers:	30
Raw Ingredient (Bulk) Api Vendors:	117
Clinical Trials:	67
Patent Applications:	2,629
What excipients (inactive ingredients) are in prazosin hydrochloride?	prazosin hydrochloride excipients list
DailyMed Link:	prazosin hydrochloride at DailyMed

Recent Clinical Trials for prazosin hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Kinnov Therapeutics	Phase 1
The Royal's Institute of Mental Health Research	Early Phase 1
Ottawa Hospital Research Institute	Early Phase 1

See all prazosin hydrochloride clinical trials

Pharmacology for prazosin hydrochloride

Drug Class	alpha-Adrenergic Blocker
Mechanism of Action	Adrenergic alpha-Antagonists

Medical Subject Heading (MeSH) Categories for prazosin hydrochloride

Adrenergic alpha-1 Receptor Antagonists
Antihypertensive Agents

Anatomical Therapeutic Chemical (ATC) Classes for prazosin hydrochloride

C02CA	Alpha-adrenoreceptor antagonists
C02C	ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING
C02	ANTIHYPERTENSIVES
C	Cardiovascular system

US Patents and Regulatory Information for prazosin hydrochloride

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Novitium Pharma	PRAZOSIN HYDROCHLORIDE	prazosin hydrochloride	CAPSULE;ORAL	210971-001	Oct 3, 2018	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Watson Labs	PRAZOSIN HYDROCHLORIDE	prazosin hydrochloride	CAPSULE;ORAL	072609-001	May 16, 1989		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Granules	PRAZOSIN HYDROCHLORIDE	prazosin hydrochloride	CAPSULE;ORAL	214608-003	Dec 23, 2021	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Purepac Pharm	PRAZOSIN HYDROCHLORIDE	prazosin hydrochloride	CAPSULE;ORAL	072921-001	May 16, 1989		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for prazosin hydrochloride

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Pfizer	MINIPRESS	prazosin hydrochloride	CAPSULE;ORAL	017442-001	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
Pfizer	MINIPRESS XL	prazosin hydrochloride	TABLET, EXTENDED RELEASE;ORAL	019775-002	Jan 29, 1992	⤷ Sign Up	⤷ Sign Up
Pfizer	MINIPRESS XL	prazosin hydrochloride	TABLET, EXTENDED RELEASE;ORAL	019775-001	Jan 29, 1992	⤷ Sign Up	⤷ Sign Up
Pfizer	MINIPRESS	prazosin hydrochloride	CAPSULE;ORAL	017442-002	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.